Home Overview Press Room Blog Publications For Students about us

Sequencing & Genomics : Displaying 330-339 of 1175

Consumer Gene Tests Face Uncertain Futureby Andrea KissackKQEDMay 5th, 2014Direct-to-consumer genetic testing took a blow last year when the government cracked down on Mountain View company 23andMe. Now, the company is working to be able to offer health information again.
Fertility Guru's IVF warning: Rich Could Pay to Have Brighter Babiesby Mario Ledwith and Fiona MacraeDaily MailMay 5th, 2014Breakthroughs in IVF could "threaten our humanity" by prompting parents to demand designer babies, warns fertility pioneer Lord Robert Winston.
Genome Sequencing: A Costly Way to Saveby Randy ShoreVancouver SunMay 4th, 2014The promise of genome sequencing is letting doctors pick the right cancer drug the first time. But the ability to target specific cancer types is giving rise to new and expensive specialty drugs.
Your Genes Are Obsoleteby Michael WhitePacific StandardMay 2nd, 2014Giving a physical meaning to the concept of a gene was a triumph of 20th-century biology, but as it turns out, this scientific success hasn’t solved the problems we hoped it would.
Advancing the Disability Rights Perspective on Bioethics Issuesby Diane ColemanNot Dead YetMay 2nd, 2014The first ever Disability Rights Leadership Institute on Bioethics drew more than 60 participants.
Pre-Pregnancy Diet 'Permanently Influences Baby's DNA'by Helen BriggsBBCApril 29th, 2014Animal experiments show diet in pregnancy can switch genes on or off, but this is the first human evidence. The research followed women in rural Gambia, where seasonal climate leads to big differences in diet between rainy and dry periods.
DNA Day Hypeby Nathaniel ComfortGenotopiaApril 25th, 2014To celebrate DNA Day, the genetic testing company 23andMe posted a DNA Day infographic that is a marvelous inadvertent evidence of genetic oversell.
Guidelines for Finding Genetic Variants Underlying Human Diseaseby Daniel MacArthur and Chris GunterGenomes UnzippedApril 24th, 2014New DNA sequencing technologies are rapidly transforming the diagnosis of rare genetic diseases, but they make it potentially easy for researchers to spin a causal narrative around genetic changes that have nothing to do with disease status.
NIPS SPINby Robert RestaThe DNA ExchangeApril 21st, 2014Every few years a new screening technology comes zooming down the prenatal pike, sometimes arriving more quickly than we might like. The latest iteration – Non-Invasive Prenatal Screening – stands head and shoulders above the rest.
Is Illumina’s $1,000 Genome a Reality? Not for Clinical Laboratory Purposes, Asserts an In Vitro Diagnostics Expert by Joseph BurnsDark DailyApril 21st, 2014Gene sequencing for clinical purposes requires more resources, including the costs of experts to interpret data to help pathologists and physicians involved in the case.
Displaying 330-339 of 1175  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760